(19)
(11) EP 0 879 285 A1

(12)

(43) Date of publication:
25.11.1998 Bulletin 1998/48

(21) Application number: 96939066.0

(22) Date of filing: 15.11.1996
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 38/ 00( . )
A61P 37/ 06( . )
C07K 7/ 02( . )
C12N 15/ 12( . )
C12P 19/ 00( . )
 A61K 31/ 00( . )
A61P 37/ 00( . )
C07K 1/ 113( . )
C07K 14/ 705( . )
C12P 9/ 00( . )
C12P 21/ 02( . )
(86) International application number:
PCT/EP1996/005039
(87) International publication number:
WO 1997/018307 (22.05.1997 Gazette 1997/22)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 16.11.1995 GB 19950023469

(71) Applicants:
  • Novartis AG
    4058 Basel (CH)
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

(72) Inventor:
  • BUEHLER, Thomas
    CH-4125 Riehen (CH)

   


(54) FAS LIGAND FUSION PROTEIN